New Technologies
FDA building sign (1).jpg
Regulatory & QualityLivaNova’s LifeSPARC System Nabs Additional FDA ClearanceLivaNova’s LifeSPARC System Nabs Additional FDA Clearance
The system is now approved for ECMO beyond six hours with patients in acute respiratory failure or acute cardiopulmonary failure.
Sign up for the QMED & MD+DI Daily newsletter.